|
Originally published In Press as doi:10.1074/jbc.M409071200 on December 8, 2004
J. Biol. Chem., Vol. 280, Issue 8, 7377-7387, February 25, 2005
Oxidation of Cholesterol by Amyloid Precursor Protein and -Amyloid Peptide*
Thomas J. Nelson and
Daniel L. Alkon
From the
Blanchette Rockefeller Neurosciences Institute, Rockville, Maryland 20850
Alzheimer's disease (AD) is characterized by accumulation of the neurotoxic peptide -amyloid, which is produced by proteolysis of amyloid precursor protein (APP). APP is a large membrane-bound copper-binding protein that is essential in maintaining synaptic function and may play a role in synaptogenesis. -Amyloid has been shown to contribute to the oxidative stress that accompanies AD. Later stages of AD are characterized by neuronal apoptosis. However, the biochemical function of APP and the mechanism of the toxicity of -amyloid are still unclear. In this study, we show that both -amyloid and APP can oxidize cholesterol to form 7 -hydroxycholesterol, a proapoptotic oxysterol that was neurotoxic at nanomolar concentrations. 7 -Hydroxycholesterol inhibited secretion of soluble APP from cultured rat hippocampal H197/IGF-IR neuronal cells and inhibited tumor necrosis factor- -converting enzyme -secretase activity but had no effect on -site APP-cleaving enzyme 1 activity. 7 -Hydroxycholesterol was also a potent inhibitor of -protein kinase C, with a Ki of 0.2 nM. The rate of reaction between cholesterol and -amyloid was comparable to the rates of cholesterol-metabolizing enzymes (kcat = 0.211 min-1). The rate of production of 7 -hydroxycholesterol by APP was 200 times lower than by -amyloid. Oxidation of cholesterol was accompanied by stoichiometric production of hydrogen peroxide and required divalent copper. The results suggest that a function of APP may be to produce low levels of 7-hydroxycholesterol. Higher levels produced by -amyloid could contribute to the oxidative stress and cell loss observed in Alzheimer's disease.
Received for publication, August 9, 2004
, and in revised form, December 7, 2004.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Blanchette Rockefeller Neurosciences Institute, 317 Academic and Research Bldg., 9601 Medical Center Dr., Rockville, MD 20850. Tel.: 301-294-7178; Fax: 301-294-7007; E-mail: tjnelson{at}brni-jhu.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. V. J. Murray, L. Liu, H. Komatsu, K. Uryu, G. Xiao, J. A. Lawson, and P. H. Axelsen
Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid beta Proteins
J. Biol. Chem.,
March 30, 2007;
282(13):
9335 - 9345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Brewer
Iron and Copper Toxicity in Diseases of Aging, Particularly Atherosclerosis and Alzheimer's Disease
Experimental Biology and Medicine,
February 1, 2007;
232(2):
323 - 335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Khan and D. L. Alkon
An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin
PNAS,
August 29, 2006;
103(35):
13203 - 13207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Tabner, O. M. A. El-Agnaf, S. Turnbull, M. J. German, K. E. Paleologou, Y. Hayashi, L. J. Cooper, N. J. Fullwood, and D. Allsop
Hydrogen Peroxide Is Generated during the Very Early Stages of Aggregation of the Amyloid Peptides Implicated in Alzheimer Disease and Familial British Dementia
J. Biol. Chem.,
October 28, 2005;
280(43):
35789 - 35792.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|